The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma

Published:2022-12-29 Issue:1 Volume:30 Page:1-13
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Xu Haoyue¹,Zhang Yongkang¹,Li Linfeng¹,Ren Yanhong¹,Qian Feng¹,Wang Lansheng¹,Ma Hongwei¹,Quan Ankang¹,Liu Hongmei¹²,Yu Rutong¹³

Affiliation:

1. Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China

2. Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China

3. Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

Funder

The Tufts Initiative on Substance Use and Addiction

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2022.2152911

Reference40 articles.

1. Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients

2. Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release

3. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

4. Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation

5. Temozolomide–Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma;Drug Resistance Updates;2024-09

2. Targeting Ferroptosis to Enhance Radiosensitivity of Glioblastoma;PROG BIOCHEM BIOPHYS;2024

3. Dual‐Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy;Advanced Materials;2024-05-13

4. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities;International Journal of Biological Macromolecules;2024-05

5. Application of nanoformulations as a strategy to optimize chemotherapeutic treatment of glioblastoma: a systematic review;Journal of Toxicology and Environmental Health, Part B;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3